FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2409420698> ?p ?o ?g. }

• W2409420698 endingPage "12400" @default.
• W2409420698 startingPage "12388" @default.
• W2409420698 abstract "ABSTRACT Comprehensive assessments of immune correlates of protection in human immunodeficiency virus (HIV) vaccine trials are essential to vaccine design. Neutralization sieve analysis compares the neutralization sensitivity of the breakthrough transmitted/founder (TF) viruses from vaccinated and control animals to infer the molecular mechanisms of vaccine protection. Here, we report a robust neutralization sieve effect in a nonhuman primate simian immunodeficiency virus (SIV) vaccine trial (DNA prime/recombinant adenovirus type 5 [rAd5] boost) (VRC-10-332) that demonstrated substantial protective efficacy and revealed a genetic signature of neutralization resistance in the C1 region of env . We found significant enrichment for neutralization resistance in the vaccine compared to control breakthrough TF viruses when tested with plasma from vaccinated study animals, plasma from chronically SIV-infected animals, and a panel of SIV-specific monoclonal antibodies targeting six discrete Env epitopes ( P < 0.008 for all comparisons). Neutralization resistance was significantly associated with the previously identified genetic signature of resistance ( P < 0.0001), and together, the results identify virus neutralization as a correlate of protection. These findings further demonstrate the in vivo relevance of our previous in vitro analyses of the SIVsmE660 challenge stock, which revealed a broad range of neutralization sensitivities of its component viruses. In sum, this report demonstrates proof-of-concept that phenotypic sieve analyses can elucidate mechanistic correlates of immune protection following vaccination and raises a cautionary note for SIV and SHIV (simian-human immunodeficiency virus) vaccine studies that employ challenge strains with envelope glycoproteins that fail to exhibit neutralization resistance profiles typical of TF viruses. IMPORTANCE With more than 2 million new infections annually, the development of an effective vaccine against HIV-1 is a global health priority. Understanding immunologic correlates of protection generated in vaccine trials is critical to advance vaccine development. Here, we assessed the role of vaccine-elicited neutralizing antibodies in a recent nonhuman primate study of a vaccine that showed significant protection against simian immunodeficiency virus (SIV) challenge and suggested a genetic signature of neutralization sensitivity. We found that breakthrough viruses able to establish infection in vaccinated animals were substantially more resistant to antibody-mediated neutralization than were viruses from controls. These findings suggest that vaccine-elicited neutralizing antibodies selectively blocked the transmission of more sensitive challenge viruses. Sieve analysis also corroborated a genetic signature of neutralization sensitivity and highlighted the impact of challenge swarm diversity. Our findings suggest an important role for neutralization sieve analyses as an informative component of comprehensive immune-correlates analyses." @default.
• W2409420698 created "2016-06-24" @default.
• W2409420698 creator A5013279511 @default.
• W2409420698 creator A5023829607 @default.
• W2409420698 creator A5043408832 @default.
• W2409420698 creator A5056797877 @default.
• W2409420698 creator A5079909867 @default.
• W2409420698 creator A5083678436 @default.
• W2409420698 creator A5090939942 @default.
• W2409420698 date "2015-12-15" @default.
• W2409420698 modified "2023-09-27" @default.
• W2409420698 title "Breakthrough Virus Neutralization Resistance as a Correlate of Protection in a Nonhuman Primate Heterologous Simian Immunodeficiency Virus Vaccine Challenge Study" @default.
• W2409420698 cites W1887985700 @default.
• W2409420698 cites W1932184285 @default.
• W2409420698 cites W1962897568 @default.
• W2409420698 cites W1966607693 @default.
• W2409420698 cites W1971729485 @default.
• W2409420698 cites W1985145726 @default.
• W2409420698 cites W1985666662 @default.
• W2409420698 cites W1992120558 @default.
• W2409420698 cites W1992194744 @default.
• W2409420698 cites W199440824 @default.
• W2409420698 cites W1996011751 @default.
• W2409420698 cites W1997677784 @default.
• W2409420698 cites W2002574877 @default.
• W2409420698 cites W2019493191 @default.
• W2409420698 cites W2024320790 @default.
• W2409420698 cites W2028101850 @default.
• W2409420698 cites W2028351296 @default.
• W2409420698 cites W2029851868 @default.
• W2409420698 cites W2035302706 @default.
• W2409420698 cites W2054351966 @default.
• W2409420698 cites W2054395228 @default.
• W2409420698 cites W2062632013 @default.
• W2409420698 cites W2062904381 @default.
• W2409420698 cites W2065353103 @default.
• W2409420698 cites W2079792142 @default.
• W2409420698 cites W2083559438 @default.
• W2409420698 cites W2083627780 @default.
• W2409420698 cites W2086382571 @default.
• W2409420698 cites W2089135598 @default.
• W2409420698 cites W2093009072 @default.
• W2409420698 cites W2094761185 @default.
• W2409420698 cites W2098013141 @default.
• W2409420698 cites W2099311529 @default.
• W2409420698 cites W2102236934 @default.
• W2409420698 cites W2102296058 @default.
• W2409420698 cites W2102730046 @default.
• W2409420698 cites W2111211467 @default.
• W2409420698 cites W2122210861 @default.
• W2409420698 cites W2126325079 @default.
• W2409420698 cites W2137015675 @default.
• W2409420698 cites W2138178197 @default.
• W2409420698 cites W2138957964 @default.
• W2409420698 cites W2142862894 @default.
• W2409420698 cites W2143421242 @default.
• W2409420698 cites W2146343022 @default.
• W2409420698 cites W2149860264 @default.
• W2409420698 cites W2150249219 @default.
• W2409420698 cites W2152048324 @default.
• W2409420698 cites W2152423731 @default.
• W2409420698 cites W2156557297 @default.
• W2409420698 cites W2157903295 @default.
• W2409420698 cites W2162478418 @default.
• W2409420698 cites W2168912344 @default.
• W2409420698 cites W2171536421 @default.
• W2409420698 cites W2240372320 @default.
• W2409420698 cites W2317254677 @default.
• W2409420698 cites W30316958 @default.
• W2409420698 doi "https://doi.org/10.1128/jvi.01531-15" @default.
• W2409420698 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4665252" @default.
• W2409420698 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26423953" @default.
• W2409420698 hasPublicationYear "2015" @default.
• W2409420698 type Work @default.
• W2409420698 sameAs 2409420698 @default.
• W2409420698 citedByCount "11" @default.
• W2409420698 countsByYear W24094206982016 @default.
• W2409420698 countsByYear W24094206982017 @default.
• W2409420698 countsByYear W24094206982018 @default.
• W2409420698 crossrefType "journal-article" @default.
• W2409420698 hasAuthorship W2409420698A5013279511 @default.
• W2409420698 hasAuthorship W2409420698A5023829607 @default.
• W2409420698 hasAuthorship W2409420698A5043408832 @default.
• W2409420698 hasAuthorship W2409420698A5056797877 @default.
• W2409420698 hasAuthorship W2409420698A5079909867 @default.
• W2409420698 hasAuthorship W2409420698A5083678436 @default.
• W2409420698 hasAuthorship W2409420698A5090939942 @default.
• W2409420698 hasBestOaLocation W24094206981 @default.
• W2409420698 hasConcept C14086860 @default.
• W2409420698 hasConcept C159047783 @default.
• W2409420698 hasConcept C203014093 @default.
• W2409420698 hasConcept C22070199 @default.
• W2409420698 hasConcept C2522874641 @default.
• W2409420698 hasConcept C2777995582 @default.
• W2409420698 hasConcept C86803240 @default.
• W2409420698 hasConceptScore W2409420698C14086860 @default.
• W2409420698 hasConceptScore W2409420698C159047783 @default.
• W2409420698 hasConceptScore W2409420698C203014093 @default.

• next